In less than eight years — the time since Lynn Matrisian, PhD, began her role as chief science officer of the Pancreatic Cancer Action Network (PanCAN) — she’s witnessed five-year survival rates for the disease jump from 6 to 9 percent.
This small but significant increase represents the meaningful progress made in recent years in treating pancreatic cancer, historically one of the deadliest of malignancies. Read more . . .